The Valley Desk

NCT07464951 · Interventional trial

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

Overall registry status Recruiting

Phase 1

Conditions Acute Myeloid Leukemia (AML)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov